Management of posterior uveal melanoma: Past, present, future

Retina

Volumn 22, Issue 2, 2002, Pages 139-142

  Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

BRACHYTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHOROID; CILIARY BODY; CLINICAL OBSERVATION; EARLY DIAGNOSIS; EDITORIAL; ENUCLEATION; EPISCLERAL PLAQUE BRACHYTHERAPY; GENE THERAPY; HUMAN; HYPERTHERMIC THERAPY; LIVER METASTASIS; OPHTHALMOSCOPY; PARTICLE RADIATION; PRACTICE GUIDELINE; PROGNOSIS; RISK FACTOR; SKIN CANCER; TREATMENT PLANNING; UVEA MELANOMA; VISUAL IMPAIRMENT;

FORECASTING; HUMANS; MELANOMA; THERAPEUTICS; UVEAL NEOPLASMS;

EID: 0036962707     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200204000-00001     Document Type: Editorial

References (33)

1. Shields JA, Shields CL. Management of posterior uveal melanoma. In: Shields JA, Shields CL, eds. Intraocular tumors. A text and atlas. Philadelphia: WB Saunders, 1992:171-205.
2. Shields JA, Shields CL. Management of posterior uveal melanoma. In: Shields JA, Shields CL, eds. Atlas of intraocular tumors. Philadelphia: Lippincott Williams & Wilkins, 1999: 113-139.
3. Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanomas. Surv Ophthalmol 1991;36:161-195.
4. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells? Br J Ophthalmol 1978;62:420-425.
5. Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 1979;87:741-760.
6. Manschot WA, van Peperzeel HA. Choroidal melanoma: enucleation or observation? A new approach. Arch Ophthalmol 1980;98:71-77.
7. Seigel D, Myers M, Ferris F III, Steinhorn SC. Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol 1979;87:761-765.
8. Curtin VT, Cavender JC. The natural course of selected malignant melanomas of the choroid and ciliary body. Mod Probl Ophthalmol 1974;12:523-527.
9. Gass JDM. Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation. Ophthalmology 1980;87:523-528.
10. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma. Long-term visual outcome in 1106 patients. Arch Ophthalmol 2000;118:1219-1228.
11. Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch Ophthalmol 1999;117: 170-177.
12. Gunduz K, Shields CL, Shields JA, Cater J, Brady LW. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extrascleral extension. Am J Ophthalmol 2000;130:97-102.
13. Char DH, Saunders W, Castro JR, et al. Helium ion therapy for choroidal melanoma. Ophthalmology 1983;90:1219-1225.
14. Gragoudas ES, Seddon J, Goitein M, et al. Current results of proton beam radiation of melanomas. Ophthalmology 1985; 92:284-291.
15. Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995;113:315-321.
16. Shields CL, Shields JA, DePotter P, Kheterpel S. Transpupillary thermotherapy in the management of choroidal melanoma. Ophthalmology 1996;103:1642-1650.
17. Shields CL, Shields JA, Cater J, et al. Transpupillary thermotherapy for choroidal melanoma. Tumor control and visual outcome in 100 consecutive cases. Ophthalmology 1998;105:581-590.
18. Shields JA, Shields CL, Shah P, Sivalingam V. Partial lamellar sclerouvectomy for ciliary body and choroidal tumors. Ophthalmology 1991;98:971-983.
19. Damato BE, Paul J, Foulds WS. Predictive factors of visual outcome after local resection of choroidal melanoma. Br J Ophthalmol 1993;77:616-623.
20. Shields CL Shields JA, Kiratli H, Cater JR, De Potter P. Risk factors for metastasis of small choroidal melanocytic lesions. Ophthalmology 1995;102:1351-1361.
21. Shields CL, Cater JC, Shields JA, Singh AD, Santos MCM, Carvalho C. Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol 2000;118:360-364.
22. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T. Tumor doubling times in metastatic malignant melanoma of the uvea. Ophthalmology 2000;107:1443-1449.
23. Straatsma BR, Fine SL, Earle JD, Hawkins BS, Diener-West M, McLaughlin JA. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 1988;95:1000-1004.
24. Bedikan AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 1995;67:1665-1670.
25. Dithmar S, Rusciano D, Lynn MJ, Lawson DH, Armstrong CA, Grossniklaus HE. Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma, Arch Ophthalmol 2000;118:1085-1089.
26. Nathan FE, Berd D, Sato T, et al. BOLD + interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy. J Exp Clin Cancer Res 1997;16:201-208.
27. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996;34:839-847.
28. Shields JA, Shields CL. Management and prognosis of retinoblastoma. In: Shields JA, Shields CL, eds. Intraocular tumors. A text and atlas. Philadelphia: WB Saunders, 1992: 114-139.
29. Shields JA. Myogenic tumors. In: Shields JA, ed. Diagnosis and management of orbital tumors. Philadelphia: WB Saunders, 1989:243-258.
30. Shields CL, Shields JA, Honavar SG, Demerci H. The clinical spectrum of ophthalmic rhabdomyosarcoma. The 2001 Henry Dubins Lecture. Ophthalmology 2001;108: 2284-2292.
31. DePotter P, Shields CL, Shields JA. Sebaceous gland carcinoma of the eyelids. In: Shields JA, ed. Update on malignant ocular tumors. International Ophthalmology Clinics. Vol 33. Boston: Little, Brown and Company, 1993:5-11.
32. Shields CL, Shields JA, Materin M, Gershenbaum E, Singh AD, Smith A. Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology 2001;108:172-178.
33. Ackerman AB. No one should die of malignant melanoma. J Am Acad Dermatol 1985;12:115-116.